These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 28933574)
1. Is there a role for kisspeptin in pathogenesis of polycystic ovary syndrome? Gorkem U; Togrul C; Arslan E; Sargin Oruc A; Buyukkayaci Duman N Gynecol Endocrinol; 2018 Feb; 34(2):157-160. PubMed ID: 28933574 [TBL] [Abstract][Full Text] [Related]
2. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome. Yilmaz SA; Kerimoglu OS; Pekin AT; Incesu F; Dogan NU; Celik C; Unlu A Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276 [TBL] [Abstract][Full Text] [Related]
3. Plasma selenium levels in Turkish women with polycystic ovary syndrome. Coskun A; Arikan T; Kilinc M; Arikan DC; Ekerbiçer HÇ Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):183-6. PubMed ID: 23490536 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of diminished ovarian reserve in Chinese women with polycystic ovary syndrome and sensitive diagnostic parameters. Jin J; Ruan X; Hua L; Tian X; Li Y; Wang L; Mueck AO Gynecol Endocrinol; 2017 Sep; 33(9):694-697. PubMed ID: 28412857 [TBL] [Abstract][Full Text] [Related]
5. Adverse Effects of Selected Markers on the Metabolic and Endocrine Profiles of Obese Women With and Without PCOS. Daghestani MH; Daghestani MH; Warsy A; El-Ansary A; Omair MA; Omair MA; Hassen LM; Alhumaidhi EM; Al Qahtani B; Harrath AH Front Endocrinol (Lausanne); 2021; 12():665446. PubMed ID: 34122339 [TBL] [Abstract][Full Text] [Related]
6. Role of anti-Müllerian hormone and testosterone in follicular growth: a cross-sectional study. Lv PP; Jin M; Rao JP; Chen J; Wang LQ; Huang CC; Yang SQ; Yao QP; Feng L; Shen JM; Feng C BMC Endocr Disord; 2020 Jul; 20(1):101. PubMed ID: 32641160 [TBL] [Abstract][Full Text] [Related]
7. Serum kisspeptin levels correlated with anti-mullerian hormone levels in women with and without polycystic ovarian syndrome. Mut A; Erel CT; İnan D; Öner YÖ Gynecol Endocrinol; 2021 May; 37(5):462-466. PubMed ID: 32964765 [TBL] [Abstract][Full Text] [Related]
8. Role of kisspeptin in polycystic ovary syndrome (PCOS). Emekci Ozay O; Ozay AC; Acar B; Cagliyan E; Seçil M; Küme T Gynecol Endocrinol; 2016 Sep; 32(9):718-722. PubMed ID: 27003383 [TBL] [Abstract][Full Text] [Related]
9. Effects of ovarian drilling in middle Black Sea region Turkish women with polycystic ovary syndrome having normal and high body mass indices. Demirturk F; Caliskan AC; Aytan H; Erkorkmaz U J Obstet Gynaecol Res; 2006 Oct; 32(5):507-12. PubMed ID: 16984519 [TBL] [Abstract][Full Text] [Related]
10. Effects of kisspeptin on pathogenesis and energy metabolism in polycystic ovarian syndrome (PCOS). Wang T; Han S; Tian W; Zhao M; Zhang H Gynecol Endocrinol; 2019 Sep; 35(9):807-810. PubMed ID: 30957568 [TBL] [Abstract][Full Text] [Related]
11. [Effect of luteinizing hormone vs follicular stimulating hormone ratio on anti-Müllerian hormone secretion and folliculogenesis in patients with polycystic ovarian syndrome]. Li Y; Wei LN; Xiong YL; Liang XY Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):567-70. PubMed ID: 21029609 [TBL] [Abstract][Full Text] [Related]
12. Serum anti-Müllerian hormone concentration in women with polycystic ovary syndrome and type 1 diabetes mellitus. Łebkowska A; Adamska A; Karczewska-Kupczewska M; Nikołajuk A; Otziomek E; Milewski R; Górska M; Wołczyński S; Kowalska I Metabolism; 2016 May; 65(5):804-811. PubMed ID: 26961579 [TBL] [Abstract][Full Text] [Related]
13. Correlation between kisspeptin and biochemical markers in obese and non-obese women with polycystic ovary syndrome. Gao M; Tao X; Zhang Q; He W; Zhao T; Yuan T Gynecol Endocrinol; 2023 Dec; 39(1):2215869. PubMed ID: 37236245 [No Abstract] [Full Text] [Related]
14. Antimullerian hormone in cases of different reproductive pathologies. Barbakadze L; Kristasashvili J Georgian Med News; 2014; (232-233):16-21. PubMed ID: 25214265 [TBL] [Abstract][Full Text] [Related]
15. Divergent Associations Between Serum Androgens and Ovarian Reserve Markers Revealed in Patients With Polycystic Ovary Syndrome. Li Y; Zhai Y; Li L; Lu Y; Su S; Liu Y; Xu Z; Xin M; Zhang Q; Cao Z Front Endocrinol (Lausanne); 2022; 13():881740. PubMed ID: 35757414 [TBL] [Abstract][Full Text] [Related]
16. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome. Kazerooni T; Dehghan-Kooshkghazi M Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019 [TBL] [Abstract][Full Text] [Related]
17. Ovarian morphology as a predictor of hormonal values in polycystic ovary syndrome. van der Westhuizen S; van der Spuy ZM Ultrasound Obstet Gynecol; 1996 May; 7(5):335-41. PubMed ID: 8774098 [TBL] [Abstract][Full Text] [Related]
18. Hypoandrogenism in association with diminished functional ovarian reserve. Gleicher N; Kim A; Weghofer A; Kushnir VA; Shohat-Tal A; Lazzaroni E; Lee HJ; Barad DH Hum Reprod; 2013 Apr; 28(4):1084-91. PubMed ID: 23427231 [TBL] [Abstract][Full Text] [Related]
19. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325 [TBL] [Abstract][Full Text] [Related]
20. Effects of Metformin Treatment on Soluble Leptin Receptor Levels in Women with Polycystic Ovary Syndrome. Liu RB; Liu Y; Lv LQ; Xiao W; Gong C; Yue JX Curr Med Sci; 2019 Aug; 39(4):609-614. PubMed ID: 31346998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]